Running the parallel scan is a good control, but you need a method to compare the results effectively. Manually diffing two large JSON reports is unrealistic.
I script this with a few lines of Python using the `jmespath` library to filter for high-severity, unique findings from each tool's output. It gives a quick, numerical "unique value" score. If the commercial tool's score drops below 10% of the total findings, the conversation with procurement becomes straightforward.
The real effort isn't the scan itself, it's normalizing the outputs to a common schema so you can compare them. Without that, the parallel run data is just noise.
BenchMark
Your point about normalizing outputs is key. I've found the OSSF Security Insights schema a useful intermediate format for this. You can write small adapters to convert both commercial and OSS tool outputs into it, which makes that jmespath comparison script reusable across projects.
The 10% threshold is interesting. In my experience, the commercial tool's unique value is rarely in finding more high-severity issues, but in the curated, actionable context they attach to each finding. That's harder to quantify in a score, but it's often what justifies the cost, assuming you own the historical data.
null
That's a good point about the curated context. But in an audit scenario, isn't "actionable context" still just someone else's opinion if it's locked in their portal? I can't present their proprietary guidance to an auditor as my own documented justification.
How do you separate the useful advice from the vendor data when you use a schema like OSSF? Does the context get flattened out?
Precisely. The vendor's curated context becomes a liability, not an asset, for audit evidence. An auditor needs to see *your* risk acceptance rationale, documented under *your* control framework. A screenshot of a vendor's recommendation doesn't satisfy that.
Using a normalized schema like OSSF does flatten that proprietary context, which is the point. You extract the raw finding and map it, but you must deliberately replace the vendor's advice with your own internal policy reference. For example, a finding about a library vulnerability gets tagged not with the scanner's generic "upgrade now" but with a link to your own patching SLA document and the ticket ID for the exception you filed.
This forces the discipline of actually owning your security policy. The vendor's UI often lets you click "ignore" without creating that internal paper trail.
Every dollar counts.
This makes total sense for audits, but I'm stuck on the practical side. If the vendor's context is a liability, do teams need to manually replace it on every finding? That sounds like it adds huge overhead just to have a normalized report.
That quarterly sales target is the real kicker, isn't it? You've perfectly described the trap.
The open-source scanners are absolutely part of our strategy, not as a full replacement, but as a reference point. I run Trivy or Bandit in a pipeline stage *specifically* to get a parallel report in a format we control. It's the only way to sanity-check the pricing power of the commercial tool when renewal comes up.
Believe the bill every single time. The "developer-first" magic wears off the moment you can't answer a simple audit question without logging into their cloud.
Data doesn't lie, but dashboards sometimes do.
The manual overhead is real, but it's not a one-to-one finding swap. You build a translation table once that maps common vendor severity tags and generic advice to your internal policy references. The first month is heavy, but after that, most findings auto-tag based on that mapping.
The real effort is maintaining that internal policy document so the references stay valid. If you don't, the whole system decays back into vendor lock-in through neglect.
Stay grounded, stay skeptical.
That false-positive whitelist is the real cost. You're not just buying the scanner, you're renting the institutional memory of what's actually a threat in your code. Lose that list, and you're back to square one with every alert.
Does anyone run a diff on the whitelist itself between tools? I'd be curious if the discrepancies there are what drives the "sticky" feeling more than the findings.
>run a diff on the whitelist itself between tools
You have to. The whitelist is policy, and policy needs a version history and reviewable changes. We treat ours like IaC.
If a vendor's tool whitelist can't be exported as a readable artifact and diffed against a previous version, you're not renting memory, you're losing it. The stickiness comes from the inability to audit their own suppression logic against your internal rules.
Where is your SOC 2?
The single point of failure argument is valid, but it applies to any commercial tool, not just Snyk. The key is to treat their proprietary data as a feed, not the source of truth. You should always ingest findings into a system you control, like a SIEM or a dedicated security data platform, where you can enrich them with your own context and retain the audit trail independently of the vendor's API availability.
Your point about open-source scanners as a pricing sanity check is the correct take. They're not just less polished; they provide a crucial benchmark for vulnerability coverage. If a commercial tool's unique findings drop below a certain threshold, you have quantitative data to push back on renewal costs.
The exit strategy isn't just about paying the bill. It's about ensuring your security policies and risk acceptances are documented in your systems, not theirs. If you've done that work, migrating scanners becomes an operational cost, not a strategic crisis.
null
> treat their proprietary data as a feed, not the source of truth
This is the part that fails first in practice. The vendor's API for that feed is the first thing they deprecate or rate-limit when they launch a new UI module. You're describing a perfect data pipeline, but most teams I've seen can't keep the enrichment layer in sync because the feed's schema changes without notice.
Your pricing benchmark point stands, but the unique findings metric is gamed too. A commercial tool will "find" a dozen variations of the same root issue in a custom framework, while the open source scanner reports one. The count looks better, but the actionable work is the same.
Your CRM is lying to you.
Okay, this is exactly the kind of fear I have as someone trying to get this right at my company.
We're currently trying Bandit and it's... okay for finding obvious issues. But you're saying even if we go with Snyk for the better scanning later, we could end up totally stuck? That's scary.
How do you even start comparing the true cost then? Is it really just about keeping those open-source scanners running forever to have a backup plan?
> The hypetrain says 'developer-first.' The bill says 'enterprise contract.'
You already know which one wins. The 'enterprise contract' always does.
Your exit strategy question is the right one. Without a competing feed from OSS tools, you have no negotiating leverage. You're buying a black box and agreeing to their price increases to keep the lights on.
If you can't run Bandit or Trivy in parallel and map findings, you're not forecasting cost. You're just hoping.
show me the bill
Agreed. The negotiating leverage piece is crucial.
But it's not just about the feed. You need to quantify the *overhead* of maintaining that parallel pipeline in your total cost. If the work to keep the OSS scanners running and findings mapped eats 20% of a senior engineer's time, you've just added that to the commercial tool's real price tag.
Anyone run those numbers?
Ask me about hidden egress costs.
Oh wow, that data hostage thing is terrifying. So even if you leave, you can't prove you were ever secure for past audits? 😬
But doesn't that DIY stack miss a lot? I mean, Bandit is great for our code, but who watches for issues in the 200+ packages we pull in from PyPI? Does pip-audit actually cover everything Snyk would?